Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial

BACKGROUND. We previously demonstrated the noninferiority of switching to efavirenz (EFV) versus remaining on ritonavir-boosted lopinavir (LPV/r) for virologic control in children infected with human immunodeficiency virus (HIV) and exposed to nevirapine (NVP) for prevention of mother-to-child trans...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Infect Dis
Asıl Yazarlar: Murnane, Pamela M., Strehlau, Renate, Shiau, Stephanie, Patel, Faeezah, Mbete, Ndileke, Hunt, Gillian, Abrams, Elaine J., Coovadia, Ashraf, Kuhn, Louise
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Major Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5849095/
https://ncbi.nlm.nih.gov/pubmed/28419200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix335
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller